CR

Chetan Raghuvanshi

Director DIN 05238909
DIN 05238909 First appointment Apr 2012
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Chetan Raghuvanshi

Data last updated:

Chetan Raghuvanshi was a Director at Chetan Homes & Construction Private Limited (from 2013) and Director at Maladies Pharmaceuticals (I) Private Limited (from 2012).

DIN 05238909
First Appointment 03 Apr 2012
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Jul 20132013Strike Off
Director03 Apr 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chetan Homes & Construction Private Limited
Maladies Pharmaceuticals (I) Private Limited
Premium access

Shareholding and investment profile for Chetan Raghuvanshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chetan Raghuvanshi

Chetan Raghuvanshi was first appointed on 03 Apr 2012 as Director at Maladies Pharmaceuticals (I) Private Limited. The most recent appointment on record is 30 Jul 2013 at Chetan Homes & Construction Private Limited.

Chetan Raghuvanshi held 2 earlier board appointments: Chetan Homes & Construction Private Limited (Director, from 30 Jul 2013); Maladies Pharmaceuticals (I) Private Limited (Director, from 03 Apr 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available